evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). With a track record of more than 120,000 successful antibody production runs for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland). You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
Looking for a particular evitria AG employee's phone or email?
The evitria AG annual revenue was $2 million in 2026.
Stefan Schmidt is the Chief Scientific Officer of evitria AG.
25 people are employed at evitria AG.
evitria AG is based in Schlieren, Zurich.
The NAICS codes for evitria AG are [541, 54171, 5417, 54, 541713].
The SIC codes for evitria AG are [87, 873].